Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6271680 | 0.91 | BLM (0.56) | BLMLMNAPTPN1ALOX15MEN1 | |
| SCHEMBL11453396 | 0.83 | BLM (0.48) | BLMLMNAPTPN1ALOX15MEN1 | |
| SCHEMBL11405869 | 0.83 | BLM (0.39) | BLMLMNAPTPN1CA1ALDH1A1 | |
| SCHEMBL11445909 | 0.83 | BLM (0.48) | BLMLMNAPTPN1ALOX15MEN1 | |
| SCHEMBL1509686 | 0.82 | TDP1 (0.37) | CA1CYP2C19ALDH1A1TDP1 | |
| SCHEMBL11405886 | 0.80 | TSHR (0.44) | CYP3A4ACE2CA1CYP2C19TDP1 | |
| Bicarbonate SCHEMBL17847293 | 0.80 | BLM (0.59) | BLMLMNAPTPN1ALOX15MEN1 | |
| SCHEMBL107548 | 0.80 | CYP2C19 (0.46) | CA1CYP2C19ALDH1A1TDP1 | |
| SCHEMBL107898 | 0.78 | CA1 (0.44) | BLMCA1ALDH1A1TDP1 | |
| SCHEMBL28716932 | 0.78 | ACE2 (0.47) | ACE2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2386535-B1 | Method for producing aldehyde and ketone | SHINETSU CHEMICAL CO (JP) | 2014-06-25 | — | — | EP | disclosed |
| US-8383863-B2 | Method for producing aldehyde and ketone | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2013-02-26 | — | — | US | disclosed |
| US-20110282102-A1 | Method for Producing Aldehyde and Ketone | SHIN-ETSU CHEMICAL CO., LTD. | 2011-11-17 | — | — | US | disclosed |
| EP-2386535-A1 | Method for producing aldehyde and ketone | Shin-Etsu Chemical Co., Ltd. (JP) | 2011-11-16 | — | — | EP | disclosed |
| US-8041455-B2 | Robotic cart pulling vehicle | AETHON, INC. (US) | 2011-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282102-A1 | Method for Producing Aldehyde and Ketone | ADH1C, ADH1A, ADH5 | BLM 4373/4885LMNA 3407/4885PTPN1 4545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.